Acrospire Investment Management’s Albany Molecular Research Inc AMRI Stock Holding History

Acrospire Investment Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,115	Closed	-$24K	–	2034
2017 Q2	$24K	Buy	+1,115	New	+$20.2K	0.02%	1431
2016 Q4	–	Sell	-3,368	Closed	-$56K	–	2577
2016 Q3	$56K	Buy	3,368 +2,300	+215%	+$34.1K	0.04%	987
2016 Q2	$14K	Sell	1,068 -4,300	-80%	-$62.7K	0.01%	1668
2016 Q1	$82K	Buy	+5,368	New	+$84.1K	0.06%	478

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Acrospire Investment Management's AMRI Position: Q3 2017 in Review

Acrospire Investment Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 1,115 shares — an estimated $24K sold.

Acrospire Investment Management first reported a position in AMRI in Q1 2016 and held it in 4 quarters. The position peaked at $82K in Q1 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Acrospire Investment Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Acrospire Investment Management sold 1,115 Albany Molecular Research Inc shares in Q3 2017, an estimated $24K.
Acrospire Investment Management first reported a position in Albany Molecular Research Inc in Q1 2016 and held it in 4 quarters.
Acrospire Investment Management's Albany Molecular Research Inc position peaked at $82K in Q1 2016.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.